Shinhung Co., Ltd (KRX:004080)
South Korea
· Delayed Price · Currency is KRW 13,690
+40 (0.29%)
Last updated: Dec 5, 2025, 9:00 AM KST
Shinhung Revenue
Shinhung had revenue of 24.10B KRW in the quarter ending September 30, 2025, with 1.10% growth. This brings the company's revenue in the last twelve months to 98.94B, down -4.71% year-over-year. In the year 2024, Shinhung had annual revenue of 101.76B, down -9.50%.
Revenue (ttm)
98.94B
Revenue Growth
-4.71%
P/S Ratio
1.31
Revenue / Employee
494.72M
Employees
200
Market Cap
129.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
| Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
| Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
| Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
| Dec 31, 2020 | 116.65B | -6.36B | -5.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |